Product Images Topamax
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 9 images provide visual information about the product associated with Topamax NDC 50458-647 by Janssen Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a graph displaying the cumulative rates for time to first seizure in patients treated with Topamax at two different doses (50mg/day and 400mg/day). The graph shows the time (in days) on the x-axis and the cumulative rates on the y-axis. The p-value for the comparison between the two doses is stated as 0.0002.*
The text seems to be a table showing the results of a study on TOPAMAX, a medication used for the prevention of migraines. The table includes the placebo dosage and different dosages of the medicine, and their effects on the average monthly migraine period rate. It also includes information about the change from the baseline to the double-blind phase of the study. The significance levels of the results are also reported.*
TopAMAX ® (topiramate) Tablets are prescription-only. It is recommended that the accompanying medication guide is dispensed to each customer before dispensing. The above text contains additional alphanumeric characters and is not readable.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.